Unlikely Valeant (VRX) Will Lose Salix (SLXP) Deal - BMO Capital

Go back to Unlikely Valeant (VRX) Will Lose Salix (SLXP) Deal - BMO Capital

Valeant Pharma (VRX) Comments on Endo Bid for Salix; Remains Committed to All-Cash Offer

March 12, 2015 6:39 AM EDT

Valeant Pharma (NYSE: VRX) issued the below statement in response to Endo International plc's (Nasdaq: ENDP) unsolicited offer to acquire Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP):

"We are firmly committed to our all-cash... More

Valeant Pharma (VRX) firmly committed to agreed upon Salix Pharma (SLXP) deal - Bloomberg

March 11, 2015 3:31 PM EDT

Valeant Pharma (NYSE: VRX) firmly committed to agreed upon Salix Pharma (NASDAQ: SLXP) deal, Bloomberg reported citing a spokesperson.

... More

Valeant Pharma (VRX) Ticks Higher as Endo (ENDP) Confirms Bid for Salix (SLXP)

March 11, 2015 2:43 PM EDT

Valeant Pharma (NYSE: VRX) shares are moving slightly to the upside following confirmation that Endo International (Nasdaq: ENDP) has moved to acquire Salix Pharma (Nasdaq: SLXP) for $175 per share in... More

Endo (ENDP) Announces $175/Share Offer for Salix (SLXP)

March 11, 2015 2:30 PM EDT

Endo International plc (Nasdaq: ENDP) confirmed that it has submitted a proposal to the Board of Directors of Salix to acquire all of the outstanding shares of common stock of Salix Pharma (Nasdaq: SLXP) in a negotiated cash and stock transaction. Based on the closing stock price of Endo on March 10, 2015, the transaction is valued at $175.00 per Salix share.

*** Under terms of the... More

Salix Pharma (SLXP) Surges on Reports of Competing Bid from Endo (ENDP)

March 11, 2015 1:12 PM EDT

Shares of Salix Pharma (NASDAQ: SLXP) zoomed higher Wednesday on reports from the Wall Street Journal that Endo Int'l (NASDAQ: ENDP) is prepared to make a competing bid for the company.

This afternoon, Endo delivered a... More

Salix Pharma (SLXP) Moves Above $158/Share Valeant (VRX) Bid as Endo (ENDP) Said to Enter Fray

March 11, 2015 12:52 PM EDT

Salix Pharma (Nasdaq: SLXP) has moved above the $165 level to $169 per share on news that Endo International (Nasdaq: ENDP) was said to offer Salix $170 - $175 per share.

Salix and Valeant (NYSE:... More

Salix Pharma (SLXP) Gains on Report of Competing Bid from Endo Int'l (ENDP) (VRX)

March 11, 2015 12:44 PM EDT

Endo Int'l (NASDAQ: ENDP) said to make competing bid for Salix Pharma (NASDAQ: SLXP).

SLXP is currently in a deal to be acquired by Valeant Pharma (NYSE: VRX) for $165/share.

... More